|1.||Wang, J: 2 articles (10/2000 - 03/2000)|
|2.||Djamali, Arjang: 1 article (09/2015)|
|3.||Redfield, Robert R: 1 article (09/2015)|
|4.||Huang, Gengwen: 1 article (09/2015)|
|5.||Zhong, Weixiong: 1 article (09/2015)|
|6.||Reese, Shannon R: 1 article (09/2015)|
|7.||Wilson, Nancy A: 1 article (09/2015)|
|8.||Doesch, Andreas O: 1 article (01/2014)|
|9.||Rohde, David: 1 article (01/2014)|
|10.||Erbel, Christian: 1 article (01/2014)|
|1.||Breast Neoplasms (Breast Cancer)
05/07/2013 - "In this study, we have evaluated the efficacy of 4TO7, a highly tumorigenic murine mammary tumor cell line, expressing glycosyl phosphatidylinositol (GPI)-anchored form of cytokine molecules alone or in combination with the costimulatory molecule B7-1 as a model for potential cell or membrane-based breast cancer vaccines. "
03/01/2007 - "Transfection of the costimulatory molecule B7-1 gene into certain murine tumors increases antitumor immunity and suppresses tumor growth. "
05/15/2001 - "Transfection of tumor cells with the gene encoding the costimulatory molecule B7-1 (CD80), the ligand for CD28 and cytotoxic T lymphocye antigen-4 on T cells, has been shown to result in potent T-cell-mediated antitumor immunity. "
03/01/2000 - "Recently, many experiments have shown that the expression of the costimulatory molecule B7-1 on tumor cells can induce tumor-specific immunity. "
12/01/1999 - "To explore the expression of B7-1 antigen (Ag), the most important costimulatory molecule for T-lymphocyte activation, on tumor cells from cancerous human tissues. "
12/01/1999 - "B7-1 antigen expression in tumor cells from cancerous human tissues."
|3.||Melanoma (Melanoma, Malignant)
05/01/1996 - "Key words: Melanoma; T cells; B7-1 costimulatory molecule (CD80); major histocompatibility complex."
05/01/1996 - "These melanoma cells had no detectable baseline surface expression of the B7-1 costimulatory molecule, but 8% to 31% of these cells became B7-1 positive with no selection procedure after gene transfer with human B7-1 cDNA. "
05/01/1996 - "Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer."
05/01/1996 - "The aim of this study was to determine if human melanoma cells could be molecularly modified by particle-mediated gene transfer with a "gene gun", using genes for interferon-gamma (IFN-gamma), the B7-1 costimulatory molecule (CD80), and human leukocyte antigen (HLA)-A2, to augment expression of both HLA molecules and B7-1. "
08/01/1996 - "The results showed that IL-12 in combination with IL-2 enhanced the autologous anti-melanoma CTL response, whereas B7.1 antigen expression on tumour cells did not increase anti-melanoma CTL generation. "
01/01/1997 - "In light of these studies, two concurrent strategies were used to improve immune responses to MUC1: a recombinant vaccinia virus was constructed containing a modified "mini" MUC1 gene containing only 10 tandem repeat sequences to minimize vaccinia-mediated rearrangement (designated rV-MUC1); and an admixture was used containing rV-MUC1 and a recombinant vaccinia virus containing the gene for the murine T-cell costimulatory molecule B7-1 (rV-B7). "
05/01/1996 - "On the basis of the reported synergistic effects of IL-12 and the costimulatory molecule B7-1 (CD80) in vitro, we immunized mice with a double recombinant vaccinia encoding both the model tumor Ag and the costimulatory molecule B7-1, designated B7-1 beta-gal rVV. "
05/01/2004 - "In this study, bone marrow-derived DC were genetically engineered to express high levels of interleukin-12 (IL-12) with or without the costimulatory molecule B7-1, by ex vivo infection with recombinant adenoviral vectors. "
01/01/1994 - "Expression of the EBV nuclear antigen complex (EBNA 1-6) was detected by 24 h post-infection, but expression of the latent membrane protein (LMP) and of the B cell activation antigen CD23 were delayed until 8 days post-infection, and were then only detectable in a subpopulation of EBNA-positive cells. "
|5.||aniline (aniline hydrobromide)
|7.||Interleukin-12 (IL 12)
|8.||Interferon-gamma (Interferon, gamma)
|10.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
|1.||Homologous Transplantation (Allograft)